
16 Mins
21 Oct 2021
The Emerging Role and Value of Homologous Recombination Deficiency Testing in Advanced Ovarian Cancer: Interviews with Four Key Opinion Leaders
Ovarian cancer is the seventh most common cancer in females,1-3 and the most lethal gynaecologic malignancy globally because of its vague…

20 Oct 2021
The Emerging Role and Value of HRD Testing in Ovarian Cancer
This episode is on the topic of ovarian cancer. Hear from two experts in the field, Professor Frederik Marmé and Professor Christina Fotopoulou, as they discuss the impact of late diagnosis and delayed treatment on patient outcomes, risk reduction strategies, and HRD testing.